Brought to you by 
Baxter buys Edwards' CRRT product line
09 Jul 2009
Executive Summary
Edwards Lifesciences has agreed to sell its hemofiltration product line (also called continuous renal replacement therapy (CRRT)) from its Critical Care unit to Baxter International, its long-term supplier.
Deal Industry
- Medical Devices
-
Medical Devices
- Monitoring Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Baxter buys Edwards' CRRT product line
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice